ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
7 announcements with these filters
Bajaj Healthcare Limited concluded its 33rd Annual General Meeting on September 21, 2026. The shareholders transacted ordinary and special business, including a final dividend declaration.
Bajaj Healthcare Limited has fixed September 14, 2026, as the record date for a 30% final dividend. The dividend of ₹1.50 per share awaits shareholder approval.
Bajaj Healthcare dispatched letters to shareholders providing the web-link for the 2025-26 Annual Report and reminding them to update their KYC details.
Bajaj Healthcare Limited submitted its Business Responsibility and Sustainability Report for the financial year 2025-26, detailing the company's operational and sustainability performance.
Bajaj Healthcare Limited has scheduled its 33rd Annual General Meeting for September 21, 2026. The Annual Report for FY 2025-26 has been dispatched to shareholders.
Bajaj Healthcare has allotted 2,500 equity shares upon the exercise of employee stock options under its 2024 scheme, slightly increasing the company's total issued equity capital.
Bajaj Healthcare received DCGI approval to manufacture and market Cenobamate API and tablets across six strengths in India. This adds a new product to its portfolio.